vimarsana.com

The Food and Drug Administration has reprimanded at least 28 companies this year, saying they failed to prove sufficient testing of ingredients used in over-the-counter drugs and consumer products for the toxins ethylene glycol (EG) and diethylene glycol (DEG), according to a Reuters analysis of agency import alerts and warning letters to manufacturers. The manufacturers include U.S.-based companies and exporters from India, South Korea, Switzerland, Canada and Egypt.

Related Keywords

India ,United States ,Massachusetts ,Usuhan ,Cholla Bukto ,South Korea ,Seoul ,Soult Ukpyolsi ,Indonesia ,Switzerland ,Egypt ,Washington ,Hyderabad ,Andhra Pradesh ,Canada ,New York ,Michele Gershberg ,Joyce Lee ,Rishika Sadam ,Sangleaf Pharma ,Peter Lindsay ,Charlene Paz ,Greg Landry ,Patrick Wingrove ,Paul Hastings ,Reuters ,Massachusetts College Of Pharmacy Health Sciences ,Drug Administration ,Suhan Aerosol ,Daxal Therapeutics ,Skyline Herbals ,Massachusetts College ,Health Sciences ,Bill Berkrot ,Healthcare Products ,Consumer Products ,Manufacturers ,Fda ,Testing Practices ,Harmaceutical Grade Ingredients ,Contamination ,Orchid Lifesciences ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.